EDRN Steering Committee Meeting, September 12-14, 2017, Seattle, WA
- 9/13/17: 0-EDRN Breast/GYN Collaborative Group Agenda
- 9/14/17: 2-Yingye Zheng-Modeling Prostate Specific Antigen (PSA) Kinetics in Prostate Cancer Surveillance
- 9/13/17: 7-Robert Schoen-An Update on ctDNA as a Cancer Biomarker
- 9/12/17: 3-Martin Sanda-Urinary RNA, Serum Biomarkers, and Prostate Cancer Specific Pet Imaging
- 9/14/17: 3-Nabihah Tayob-Improved Early Detection of Hepatocellular Carcinoma with Longitudinal Biomarker Screening Algorithms
- 9/13/17: 4-Steven Dubinett-The Immuno-biology of Pulmonary Premalignancy
- 9/13/17: 8-Paul Boutros-Integrated Genomic and Proteomic Biomarkers for Non-Invasive Identification of Aggressive Prostate Cancer
- 9/12/17: 0-Garnet Anderson Welcome Address
- 9/12/17: 4-Dean Brenner-Validation of Colon Cancer Biomarkers
- 9/14/17: 0-Margaret Pepe-An Introduction into Longitudinal Biomarker Evaluations
- 9/14/17: 4-William Grady-GI Collaborative Group Colorectal Cancer Projects
- 1: 32nd EDRN Steering Committee Meeting Agenda
- 9/13/17: 9-Scott Tomlins-Development of Prostate Cancer Early Detection and Prognostic Biomarkers
- 9/13/17: 1-EDRN GI Collaborative Group Agenda
- 9/12/17: 5-Randall Brand-Mucins and their Associated Serological Panel for Diagnosis of Pancreatic Cancer
- 9/13/17: 2-EDRN Lung Collaborative Group Meeting
- 9/14/17: 5-Anirban Maitra-EDRN Prostate Cancer Collaborative Group Update
- 9/13/17: 3-EDRN Prostate Collaborative Group Meeting
- 9/13/17: 10-Jeff Marks & Cha-Mei Tang: A Unique Tumor Derived Macrophage is a New Blood-based Biomarker for Cancer Screening and Diagnosis
- 9/13/17: 5-Harvey Pass-Ten Years of Mesothelioma Biomarkers: Controversy and Evolution
- 9/14/17: 6-Christopher Li-Breast Cancer Collaborative Group Updates on Team Projects
- 9/14/17: 1-Steven Skates-Longitudinal Biomarker Interpretation for Early Detection of Ovarian Cancer
- 9/12/17: 6-Anirban Maitra-Biomarkers for Pancreatic Cancer Early Detection
- 9/12/17: 1-Sudhir Srivastava-EDRN State of the Science
- 9/13/17: 11-Amanda Paulovich-Identifying Candidate Breast Cancer Biomarkers in the Plasma of Xenografted Mice
- 9/12/17: 10-Gerard Davis-Experiences and Insights on Partnering in Biomarker Discovery towards Clinical Translation
- 9/14/17: 7-Steven Skates-Ovarian Cancer Team Projects
- 9/12/17: 11-Carolina Livi-Elucidating Cancer Mechanisms through Integrated Biology
- 9/12/17: 7a-Christopher Li-FHCRC CVC Updates in Breast and Colon Cancer Early Detection
- 9/12/17: 12-Lawrence LaPointe-Elucidating Cancer Mechanisms through Integrated Biology
- 9/12/17: 7b-Paul Lampe-FHCRC CVC Updates in Breast and Colon Cancer Early Detection
- 9/12/17: 13-Jonathan Bibliowicz-Illumina's Cancer Research Portfolio and Dedicated Workflows
- 9/12/17: 8-Robert Bast-Biomarkers for Ovarian Cancer Early Detection
- 9/12/17: 14-Sanford Stass-University of Maryland Biomarker Reference Laboratory
- 9/14/17-8-Pierre Massion-Lung Cancer Collaborative Group Update
- 9/12/17:15-Daniel Chan-Johns Hopkins University Biomarker Reference Laboratory
- 9/12/17: 9-Pierre Massion-Validation of Lung Cancer Biomarkers: Where the Rubber Meets the Road
- 9/13/17: 6-Daniel Barnett-The sTRA Antigen: A New Blood and Tissue Biomarker for Pancreatic Cancer
- 9/14/17-9-Harvey Pass-Plans for LTP3
- 9/12/17: 2-Hoifung Poon-Deep Learning for Precision Medicine